Clinical heterogeneity and differential diagnosis of atopic dermatitis

British Journal of Dermatology

Volumn 170, Issue SUPPL. 1, 2014, Pages 2-6

  Deleuran, M ^a   Vestergaard, C ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ATOPIC DERMATITIS; CHRONIC DISEASE; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; HUMAN; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SYMPTOM; DERMATITIS, ATOPIC; DERMATITIS, SEBORRHEIC; IMMUNE SYSTEM DISEASES; INFANT; ONSET AGE; PRESCHOOL CHILD; SKIN DISEASES, GENETIC; SKIN DISEASES, INFECTIOUS; SKIN NEOPLASMS;

AGE OF ONSET; CHILD, PRESCHOOL; CHRONIC DISEASE; DERMATITIS, ATOPIC; DERMATITIS, SEBORRHEIC; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNE SYSTEM DISEASES; INFANT; RECURRENCE; SKIN DISEASES, GENETIC; SKIN DISEASES, INFECTIOUS; SKIN NEOPLASMS;

EID: 84902773105     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/bjd.12933     Document Type: Review

References (22)

1. Hanifin JM, Rajka G,. Diagnostic features of atopic dermatitis. Acta Derm Venereol Suppl 1980; 92: 44-7.
2. Olesen AB, Ellingsen AR, Larsen FS, et al,. Atopic dermatitis may be linked to whether a child is first- or second-born and/or the age of the mother. Acta Derm Venereol 1996; 76: 457-60.
3. Palmer CN, Irvine AD, Terron-Kwiatkowski A, et al,. Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet 2006; 38: 441-6.
4. Carson CG, Rasmussen MA, Thyssen JP, et al,. Clinical presentation of atopic dermatitis by filaggrin gene mutation status during the first 7 years of life in a prospective cohort study. PLoS ONE 2012; 7: e48678.
5. Böhme M, Svensson A, Kull I, Wahlgren CF,. Hanifin's and Rajka's minor criteria for atopic dermatitis: which do 2-year-olds exhibit? J Am Acad Dermatol 2000; 43: 785-92.
6. Wütrich B,. Minimal variants of atopic eczema. In: Handbook of Atopic Eczema (, Ring J, Przybilla B, Ruzicka T, eds), 2nd edn. Berlin, Heidelberg: Springer-Verlag, 2006; 74-83.
7. Silverberg JI, Hanifin J, Simpson EL,. Climatic factors are associated with childhood eczema prevalence in the United States. J Invest Dermatol 2013; 133: 1752-9.
8. Sutton RL,. Summertime pityriasis of the elbow and knee. In: Disease of the Skin (, Sutton RL, ed.), 2nd edn. St Louis: CV Mosby Co., 1956; 898.
9. Naldi L, Rebora A,. Clinical practice. Seborrheic dermatitis. N Engl J Med 2009; 360: 387-96.
10. Simonsen AB, Deleuran M, Johansen JD, Sommerlund M,. Contact allergy and allergic contact dermatitis in children-a review of current data. Contact Dermatitis 2011; 65: 254-65.
11. Fastenberg M, Morrell DS,. Acral papules: Gianotti-Crosti syndrome. Pediatr Ann 2007; 36: 800-4.
12. Prasad AS,. Zinc in human health: effect of zinc on immune cells. Mol Med 2008; 14: 353-7.
13. Chouela E, Abeldaño A, Pellerano G, Hernández MI,. Diagnosis and treatment of scabies: a practical guide. Am J Clin Dermatol 2002; 3: 9-18.
14. Bieber T,. Atopic dermatitis. N Engl J Med 2008; 358: 1483-94.
15. Rudikoff D,. The relationship between HIV infection and atopic dermatitis. Curr Allergy Asthma Rep 2002; 2: 275-81.
16. Reunala T,. Dermatitis herpetiformis: coeliac disease of the skin. Ann Med 1998; 30: 416-18.
17. Tsuruta D, Ishii N, Hashimoto T,. Diagnosis and treatment of pemphigus. Immunotherapy 2012; 4: 735-45.
18. Wollina U,. Cutaneous T cell lymphoma: update on treatment. Int J Dermatol 2012; 51: 1019-36.
19. Badalian-Very G, Vergilio JA, Fleming M, Rollins BJ,. Pathogenesis of Langerhans cell histiocytosis. Annu Rev Pathol 2013; 8: 1-20.
20. Chavanas S, Bodemer C, Rochat A, et al,. Mutations in SPINK5, encoding a serine protease inhibitor, cause Netherton syndrome. Nat Genet 2000; 25: 141-2.
21. Schimke LF, Sawalle-Belohradsky J, Roesler J, et al,. Diagnostic approach to the hyper-IgE syndromes: immunologic and clinical key findings to differentiate hyper-IgE syndromes from atopic dermatitis. J Allergy Clin Immunol 2010; 126: 611-17 e1.
22. Engelhardt KR, McGhee S, Winkler S, et al,. Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome. J Allergy Clin Immunol 2009; 124: 1289-302, e4.